JP2012502017A5 - - Google Patents

Download PDF

Info

Publication number
JP2012502017A5
JP2012502017A5 JP2011525657A JP2011525657A JP2012502017A5 JP 2012502017 A5 JP2012502017 A5 JP 2012502017A5 JP 2011525657 A JP2011525657 A JP 2011525657A JP 2011525657 A JP2011525657 A JP 2011525657A JP 2012502017 A5 JP2012502017 A5 JP 2012502017A5
Authority
JP
Japan
Prior art keywords
tuberculosis
rifampin
isoniazid
group
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011525657A
Other languages
English (en)
Japanese (ja)
Other versions
JP5661037B2 (ja
JP2012502017A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2009/053796 external-priority patent/WO2010026526A1/en
Publication of JP2012502017A publication Critical patent/JP2012502017A/ja
Publication of JP2012502017A5 publication Critical patent/JP2012502017A5/ja
Application granted granted Critical
Publication of JP5661037B2 publication Critical patent/JP5661037B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011525657A 2008-09-03 2009-08-31 結核についての併用療法 Expired - Fee Related JP5661037B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9387908P 2008-09-03 2008-09-03
US61/093,879 2008-09-03
PCT/IB2009/053796 WO2010026526A1 (en) 2008-09-03 2009-08-31 Combination therapy for tuberculosis

Publications (3)

Publication Number Publication Date
JP2012502017A JP2012502017A (ja) 2012-01-26
JP2012502017A5 true JP2012502017A5 (OSRAM) 2014-06-26
JP5661037B2 JP5661037B2 (ja) 2015-01-28

Family

ID=41279484

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011525657A Expired - Fee Related JP5661037B2 (ja) 2008-09-03 2009-08-31 結核についての併用療法

Country Status (14)

Country Link
US (3) US20110190199A1 (OSRAM)
EP (1) EP2340022B1 (OSRAM)
JP (1) JP5661037B2 (OSRAM)
KR (1) KR101318189B1 (OSRAM)
CN (1) CN102143748A (OSRAM)
AU (1) AU2009288820A1 (OSRAM)
BR (1) BRPI0918802A2 (OSRAM)
CA (1) CA2735229C (OSRAM)
IL (1) IL211293A (OSRAM)
MX (1) MX2011002348A (OSRAM)
NZ (1) NZ591169A (OSRAM)
RU (1) RU2484819C2 (OSRAM)
WO (1) WO2010026526A1 (OSRAM)
ZA (1) ZA201101742B (OSRAM)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2464016C2 (ru) * 2010-06-11 2012-10-20 Ольга Германовна Челнокова Способ лечения туберкулеза
ES2395304B1 (es) * 2011-05-20 2014-01-16 Interquim, S.A. Procedimiento de obtención de una tiofen-2-carboxamida.
CN102786516B (zh) * 2012-08-21 2014-10-01 湖南师范大学 一种利伐沙班的合成方法
CN103869040B (zh) * 2012-12-14 2016-12-28 上海科胜药物研发有限公司 一种特立齐酮中d‑环丝氨酸含量的测定分析方法
WO2015126922A2 (en) * 2014-02-18 2015-08-27 Stc. Unm Rapid phenotype tests for antitubercular drug sensitivity and resistance
EA201700155A1 (ru) * 2014-10-20 2017-10-31 Товарищество С Ограниченной Ответственностью "Фармацевтическая Компания "Ромат" Фармацевтическая композиция для лечения туберкулеза
JP2017533220A (ja) * 2014-11-03 2017-11-09 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 結核処置のための多剤療法
FI3250182T3 (fi) * 2015-01-27 2023-06-28 Janssen Pharmaceutica Nv Dispergoituvia koostumuksia
HK1254620A1 (zh) * 2015-10-14 2019-07-26 结核病药物开发全球联盟公司 联合抗菌组合物以及短疗程抗菌方案
WO2017066964A1 (en) 2015-10-22 2017-04-27 Merck Sharp & Dohme Corp. Oxazolidinone compounds and methods of use thereof as antibacterial agents
BR102015027449B1 (pt) 2015-10-29 2021-02-17 Fundação Oswaldo Cruz composição farmacêutica
RU2627611C2 (ru) * 2015-10-30 2017-08-09 Акционерное общество "Фармасинтез" (АО "Фармасинтез") Противотуберкулезная фармацевтическая композиция, содержащая тиоацетазон
US10472687B2 (en) 2016-01-08 2019-11-12 Institute For Systems Biology Methods to identify antituberculosis compounds
RU2650633C2 (ru) * 2016-06-02 2018-04-16 Государственное бюджетное учреждение Республики Саха (Якутия) "Научно-практический центр "Фтизиатрия" Способ лечения инфильтративного туберкулеза легких с множественной лекарственной устойчивостью
CN105853461A (zh) * 2016-06-14 2016-08-17 黄峰 一种治疗肺结核的药物组合
CN106580915B (zh) * 2016-10-13 2019-11-08 中国人民解放军第三〇九医院 一种载利福喷丁和利奈唑胺的缓释微球及其制备方法和用途
CN106581048A (zh) * 2016-12-07 2017-04-26 郑州郑先医药科技有限公司 一种治疗肺结核的西药组合及其制备方法
KR102082285B1 (ko) * 2017-04-13 2020-02-28 충남대학교산학협력단 세포내 결핵균 제어를 위한 Nutlin-3α (뉴트린-3α) 및 p53 발현 조절 조성물 또는 방법
WO2018190680A1 (ko) * 2017-04-13 2018-10-18 충남대학교산학협력단 세포내 결핵균 제어를 위한 뉴트린-3α 및 피53 발현 조절 조성물 또는 방법
CN107243008B (zh) * 2017-04-13 2021-03-30 中国科学院广州生物医药与健康研究院 吡唑并[1,5-a]吡啶类化合物的新应用及一种治疗脓肿分枝杆菌感染的组合物
WO2018191628A1 (en) * 2017-04-14 2018-10-18 The Regents Of The University Of California Multi-drug therapies for tuberculosis treatment
RU2702607C1 (ru) * 2018-07-25 2019-10-08 Федеральное государственное бюджетное учреждение "Новосибирский научно-исследовательский институт туберкулеза" Министерства здравоохранения Российской Федерации (ФГБУ "ННИИТ" Минздрава России) Способ лечения туберкулеза мочевого пузыря
CN109223778B (zh) * 2018-11-16 2021-07-27 上海市肺科医院 C24h24n6o2s3在制备抗结核菌药物中的用途
CN110441434A (zh) * 2019-08-29 2019-11-12 重庆华邦胜凯制药有限公司 Gc-ms分离测定对氨基水杨酸中相关杂质的方法
WO2021188186A2 (en) * 2020-03-18 2021-09-23 The Board Of Trustees Of The Leland Stanford Junior University Detection of gene polymorphisms
WO2021184339A1 (en) * 2020-03-20 2021-09-23 Merck Sharp & Dohme Corp. Oxazolidinone compound and methods of use thereof as an antibacterial agent
EP4164645A4 (en) * 2020-06-15 2024-07-10 The Global Alliance for TB Drug Development, Inc. COMBINED ANTIBACTERIAL COMPOSITION AND ANTIBACTERIAL THERAPY METHOD
WO2021257461A1 (en) * 2020-06-15 2021-12-23 Mylan Laboratories Limited Combination antibacterial composition and method for antibacterial therapy
EP4271679A4 (en) * 2021-02-01 2024-09-11 The Global Alliance for TB Drug Development, Inc. AMORPHOUS FORM OF PRETOMANIDES
CN113730550B (zh) * 2021-04-06 2023-08-18 中国医学科学院医药生物技术研究所 博宁霉素在治疗耐药性结核病中的应用
CN114354804B (zh) * 2021-12-31 2025-03-18 深圳市第三人民医院(深圳市肝病研究所) 试剂盒和样本中抗结核药物及其代谢物的检测方法
CN117045657A (zh) * 2022-05-12 2023-11-14 广州嘉越医药科技有限公司 一种药物组合及其应用
WO2024035618A1 (en) * 2022-08-10 2024-02-15 Merck Sharp & Dohme Llc Processes for preparing oxazolidinone compounds
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same
CN120004814B (zh) * 2025-02-13 2025-08-12 山西立业制药有限公司 一种氯法齐明乙醇晶型化合物及其制备方法和应用、药物组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688792A (en) * 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
WO2009025820A2 (en) * 2007-08-21 2009-02-26 Stc. Unm Rationally improved isoniazid and ethionamide derivatives and activity through selective isotopic substitution

Similar Documents

Publication Publication Date Title
JP2012502017A5 (OSRAM)
RU2011108026A (ru) Комбинированная терапия туберкулеза
ES2306146T3 (es) Uso de derivados de quinolina sustituidos para el tratamiento de enfermedades micobacterianas resistentes a farmacos.
JP2008500992A5 (OSRAM)
RU2011118619A (ru) Аэрозольные фторхинолоны и их применения
JP2007519649A5 (OSRAM)
JP2017528487A5 (OSRAM)
JP2015512406A5 (OSRAM)
JP2020505408A5 (OSRAM)
JP2016538313A5 (OSRAM)
JP2016512531A5 (OSRAM)
JP2017081959A (ja) 免疫関連疾患及び炎症性疾患の治療における３−（５−アミノ−２−メチル−４−オキソキナゾリン−３（４ｈ）−イル）ピペリジン−２，６−ジオンの使用
JP2005538099A5 (OSRAM)
JP2017528507A5 (OSRAM)
JP2020512337A5 (OSRAM)
IL205501A (en) Preparation of preparations for the treatment of arthritis
JP2021505575A5 (OSRAM)
RU2014115290A (ru) Производные 1-фенил 2-пиридинилалкиловых спиртов в качестве ингибиторов
JP2015521617A5 (OSRAM)
JP2018522861A5 (OSRAM)
JP2010527984A5 (OSRAM)
JP2012523437A5 (OSRAM)
JP2009513713A5 (OSRAM)
RU2013130878A (ru) Гидроксилированные производные аминотриазола в качестве агонистов рецептора alx
JP2009519350A5 (OSRAM)